Comparing Denosumab vs Teriparatide
Denosumab | Teriparatide |
|
---|
Denosumab | Teriparatide |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
Denosumab is an injection that can be self-administered once every six months for the treatment of osteoporosis. It has been associated with an increased risk of fractures on discontinuation... View more |
Prescription only
Teriparatide mimics the action of parathyroid hormone to regulate calcium and phosphate metabolism and is given to people with osteoporosis at high risk of fractures. It is injected under the skin... View more |
Related suggestions Osteoporosis
|
|||||||
More about Denosumab | More about Teriparatide | ||||||||
Ratings & Reviews | |||||||||
Denosumab has an average rating of 3.0 out of 10 from a total of 398 ratings on Drugs.com. 17% of reviewers reported a positive effect, while 74% reported a negative effect. |
Teriparatide has an average rating of 5.4 out of 10 from a total of 173 ratings on Drugs.com. 39% of reviewers reported a positive effect, while 39% reported a negative effect. |
||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Denosumab side effects |
View all Teriparatide side effects |
||||||||
Drug Class | |||||||||
Generic Availability | |||||||||
N/A |
Lower cost generic |
||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Teriparatide prices |
||||||||
Dosage Forms | |||||||||
N/A |
|
||||||||
Brand Names | |||||||||
Bomyntra, Conexxence, Jubbonti, Osenvelt, Ospomyv, Prolia, Stoboclo, Wyost, Xbryk, Xgeva View more | Bonsity, Forteo | ||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
609.6 hours |
1 hour |
||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | |||||||||
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
A total of 311 drugs are known to interact with Denosumab:
|
A total of 6 drugs are known to interact with Teriparatide:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Disease Interactions | |||||||||
First Approval Date | |||||||||
N/A |
November 26, 2002 |
||||||||
WADA Class View classifications | |||||||||
N/A |
N/A |
||||||||
More Information | |||||||||
Patient Resources | |||||||||
Professional Resources | |||||||||
Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.